These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8358878)

  • 1. Heart failure: drug therapy in the nineties and beyond.
    Conti CR
    Clin Cardiol; 1993 Jun; 16(6):459-60. PubMed ID: 8358878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flosequinan for heart failure.
    Med Lett Drugs Ther; 1993 Mar; 35(892):23-4. PubMed ID: 8441362
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flosequinan in chronic heart failure: how is exercise capacity improved?
    Banning AP; Ramsey MW; Jones EA; Evans W; Carolan G; Jones CH; Henderson AH
    Eur J Clin Pharmacol; 1996; 51(2):133-8. PubMed ID: 8911877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy of congestive heart failure].
    Sasayama S
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1770-7. PubMed ID: 9410998
    [No Abstract]   [Full Text] [Related]  

  • 7. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure.
    McKelvie R; McConachie D; Yusuf S
    Eur Heart J; 1994 May; 15 Suppl B():9-13; discussion 26-30. PubMed ID: 8076660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic vasodilator therapy with flosequinan in congestive heart failure.
    Haas GJ; Binkley PE; Leier CV
    Clin Cardiol; 1990 Jun; 13(6):414-20. PubMed ID: 2188766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flosequinan: a new vasodilator for the treatment of heart failure.
    Dutka DP; Cleland JG
    Br J Hosp Med; 1993 May 5-18; 49(9):654-5. PubMed ID: 8508260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasodilator agents in chronic heart failure: which is the best option?].
    Corbalán R; Kunstmann S; Jalil J
    Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic advances in heart failure.
    Meinertz T; Drexler H; Just H
    Cardiovasc Drugs Ther; 1988 Nov; 2(Suppl 1):413-418. PubMed ID: 27722847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for congestive heart failure in the late 20th century.
    Maxwell LP; Jain A
    W V Med J; 1993 Apr; 89(4):148-51. PubMed ID: 8098171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure: clinical implications of recent trials.
    Pitt B; Nicklas JM
    Contemp Intern Med; 1994 Jun; 6(6):47-55. PubMed ID: 10150367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congestive heart failure: new therapeutic strategies.
    Pitt B
    Clin Cardiol; 1992 Sep; 15 Suppl 1():I2-4. PubMed ID: 1395211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of flosequinan in heart failure.
    Cowley AJ
    Am Heart J; 1991 Mar; 121(3 Pt 1):983-8. PubMed ID: 2000777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.
    Remme WJ
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):375-96. PubMed ID: 2487535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flosequinan for congestive heart failure: what promise does it hold?
    Hampton JR
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1313-5. PubMed ID: 2278865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.